These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 1678204)

  • 1. Interactions between non-steroidal anti-inflammatory drugs and H2-receptor antagonists or prostaglandin analogues.
    Dixon JS; Page MC
    Rheumatol Int; 1991; 11(1):13-8. PubMed ID: 1678204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic interactions between NSAIDs (indomethacin or sulindac) and H2-receptor antagonists (cimetidine or ranitidine) in human volunteers.
    Delhotal-Landes B; Flouvat B; Liote F; Abel L; Meyer P; Vinceneux P; Carbon C
    Clin Pharmacol Ther; 1988 Oct; 44(4):442-52. PubMed ID: 2901930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review: interactions between H2-antagonists and non-steroidal anti-inflammatory drugs.
    Howden CW
    Aliment Pharmacol Ther; 1988 Apr; 2(2):93-100. PubMed ID: 2908753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs.
    Verbeeck RK
    Clin Pharmacokinet; 1990 Jul; 19(1):44-66. PubMed ID: 2199127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug interactions with non steroidal anti-inflammatory drugs (NSAIDs).
    Weinblatt ME
    Scand J Rheumatol Suppl; 1989; 83():7-10. PubMed ID: 2576330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of meloxicam with cimetidine, Maalox, or aspirin.
    Busch U; Heinzel G; Narjes H; Nehmiz G
    J Clin Pharmacol; 1996 Jan; 36(1):79-84. PubMed ID: 8932547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxaprozin and piroxicam, nonsteroidal antiinflammatory drugs with long half-lives: effect of protein-binding differences on steady-state pharmacokinetics.
    Karim A; Noveck R; McMahon FG; Smith M; Crosby S; Adams M; Wilton J
    J Clin Pharmacol; 1997 Apr; 37(4):267-78. PubMed ID: 9115051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic-pharmacodynamic drug interactions with nonsteroidal anti-inflammatory drugs.
    Brouwers JR; de Smet PA
    Clin Pharmacokinet; 1994 Dec; 27(6):462-85. PubMed ID: 7882636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pharmacokinetic interaction between cimetidine or ranitidine and lornoxicam.
    Ravic M; Salas-Herrera I; Johnston A; Turner P; Foley K; Rosenow DE
    Postgrad Med J; 1993 Nov; 69(817):865-6. PubMed ID: 8290432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No effect of short term ranitidine intake on diclofenac pharmacokinetics.
    Leucuţa A; Vlase L; Farcau D; Nanulescu M
    Rom J Gastroenterol; 2004 Dec; 13(4):306-8. PubMed ID: 15624028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of H2 receptor antagonists on the disposition of flurbiprofen enantiomers.
    Small RE; Cox SR; Adams WJ
    J Clin Pharmacol; 1990 Jul; 30(7):660-4. PubMed ID: 2391398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of nonsteroidal anti-inflammatory drug-associated gastric and duodenal damage. Efficacy of antisecretory drugs and mucosal protective compounds.
    Pipkin G; Mills JG
    Dig Dis; 1995 Jan; 13 Suppl 1():75-88. PubMed ID: 7697904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the influence of antacids and H2 antagonists on the absorption of moxifloxacin after oral administration of a 400mg dose to healthy volunteers.
    Stass H; Böttcher MF; Ochmann K
    Clin Pharmacokinet; 2001; 40 Suppl 1():39-48. PubMed ID: 11352441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporine and nonsteroidal antiinflammatory drugs: exploring potential drug interactions and their implications for the treatment of rheumatoid arthritis.
    Kovarik JM; Mueller EA; Gerbeau C; Tarral A; Francheteau P; Guerret M
    J Clin Pharmacol; 1997 Apr; 37(4):336-43. PubMed ID: 9115060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exacerbation of nonsteroidal anti-inflammatory drug-induced small intestinal lesions by antisecretory drugs in rats: the role of intestinal motility.
    Satoh H; Amagase K; Takeuchi K
    J Pharmacol Exp Ther; 2012 Nov; 343(2):270-7. PubMed ID: 22854201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of oxaprozin with acetaminophen, cimetidine, and ranitidine.
    Scavone JM; Greenblatt DJ; Matlis R; Harmatz JS
    Eur J Clin Pharmacol; 1986; 31(3):371-4. PubMed ID: 3792438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxaprozin: a once-daily nonsteroidal anti-inflammatory drug.
    Miller LG
    Clin Pharm; 1992 Jul; 11(7):591-603. PubMed ID: 1617910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic and pharmacodynamic properties of histamine H2-receptor antagonists. Relationship between intrinsic potency and effective plasma concentrations.
    Lin JH
    Clin Pharmacokinet; 1991 Mar; 20(3):218-36. PubMed ID: 1673880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of gastric ulcer relapse induced by indomethacin in rats by a mutein of basic fibroblast growth factor.
    Satoh H; Asano S; Maeda R; Murakami I; Inada I; Sato F; Shino A
    Jpn J Pharmacol; 1997 Mar; 73(3):229-41. PubMed ID: 9127818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FR145715, a novel histamine H2 receptor antagonist, with specific anti-Helicobacter pylori activities.
    Ishikawa H; Ito H; Higaki M; Higaki M; Matsumoto Y; Kamimura T; Katsura Y; Tomishi T; Inoue Y; Takasugi H; Tomoi M; Krakowka S; Yoshida K
    Eur J Pharmacol; 1999 Aug; 378(3):299-310. PubMed ID: 10493106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.